FERRARA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.518
EU - Europa 1.393
AS - Asia 306
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 1
Totale 3.222
Nazione #
US - Stati Uniti d'America 1.510
UA - Ucraina 366
IE - Irlanda 302
SE - Svezia 281
HK - Hong Kong 98
IT - Italia 94
FI - Finlandia 92
DE - Germania 81
VN - Vietnam 81
RU - Federazione Russa 74
CN - Cina 52
SG - Singapore 36
GB - Regno Unito 30
JP - Giappone 19
CH - Svizzera 17
FR - Francia 14
TR - Turchia 11
AT - Austria 10
BE - Belgio 9
CA - Canada 8
CZ - Repubblica Ceca 5
NL - Olanda 5
UZ - Uzbekistan 5
PL - Polonia 4
EU - Europa 3
GR - Grecia 3
MD - Moldavia 3
IN - India 2
LB - Libano 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
DK - Danimarca 1
ES - Italia 1
SO - Somalia 1
Totale 3.222
Città #
Chandler 343
Dublin 302
Jacksonville 162
San Mateo 154
Hong Kong 98
Medford 86
Princeton 86
Dong Ket 81
Ann Arbor 73
Des Moines 57
Wilmington 56
Altamura 43
Lawrence 41
Perugia 38
Andover 37
Beijing 37
Singapore 22
Norwalk 21
Saint Petersburg 21
Woodbridge 20
Boardman 19
Tokyo 19
Falls Church 11
Izmir 11
Moscow 11
Brussels 9
New York 9
Helsinki 8
Dearborn 7
San Paolo di Civitate 6
Ashburn 5
Edmonton 5
Lausanne 5
Los Angeles 5
Auburn Hills 4
Bromma 3
Cambridge 3
Chisinau 3
Frankfurt Am Main 3
San Diego 3
Chicago 2
Den Haag 2
Fabriano 2
Foligno 2
Groningen 2
Lansing 2
Pune 2
Redmond 2
Southend 2
Stockholm 2
Tappahannock 2
Amsterdam 1
Arlington 1
Copenhagen 1
Corner Brook 1
Fairfield 1
Falkirk 1
Freiburg 1
Hanover 1
Hebei 1
Houston 1
Kiev 1
Montepulciano 1
Pavia 1
Richmond Hill 1
Stoke-on-Trent 1
Toronto 1
Totale 1.965
Nome #
Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. 106
A decade of interferon-γ release assays: quest for the holy grail to diagnose latent infection with mycobacterium tuberculosis? 88
Basi genetiche della predisposizione alla tubercolosi (TB) ed alle micobatteriosi non tubercolari. 83
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. 83
Intra-abdominal bleeding during treprostinil infusion in a patient with pulmonary arterial hypertension 74
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. 68
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. 68
A method to quantify mycobacteria infection of cells from in vitro experiments 66
Il trattamento della tubercolosi. 64
Chronic empyema: importance of preventing complications in the management of pleural effusions 64
Long term Moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs. 63
Sarcoidosi: patogenesi 60
[Are targeted interventions needed in foreigner workers with latent tubercular infection? A study on anti-tubercular treatment compliance among health care workers] 59
Gender and other risk factors for multidrug-resistant (MDR) tuberculosis (TB) among migrants to Milan, Italy 53
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. 53
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. 53
Combination fluticasone end salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children 51
A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test 48
Alveolar macrophages produce CCL18 during early phases infection by M. tuberculosis 48
Macrolides for chronic asthma. 46
Trends and challenges in tuberculosis in a medium-sized southern European setting 46
Xpert MTB/RIF test for tuberculosis. 46
Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts. 45
Clinical and operational value of the XDR-TB definition. 45
Combination fluticasone and salmeterol vs fixed dose combination budesonide and formoterol in adults and children 44
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 44
Cough mechanical assistance in neuromuscular patients with respiratory failure: a retrospective evaluation 43
Clinical use of levofloxacin in the long term treatment of drug resistant tuberculosis 43
Corticosteroids for idiophatic pulmonary fibrosis. 41
Clinical use of Levofloxacin in the long term treatment of drug resistant tuberculosis. 41
Community acquired pneumonia in internal medicine: a one-year retrospective study based on pneumonia severity index. 41
Screening of immigrants in the UK for latent tuberculosis. 40
C’è esigenza di interventi mirati nei lavoratori stranieri affettida infezione tubercolare latente? Uno studio sulla compliancealla terapia antitubercolare in operatori sanitari 40
Use of an IGRA test for prescribing latent TB infection therapy in 374 immigrants applying to night shelters in Milan, Italy 40
Macrolides for chronic asthma. 39
Dossier Tubercolosi. La tubercolosi agli inizi del XXI secolo: diagnosi e terapia 39
Micobatteriosi non tubercolari 38
Intravenous Immunoglobulin (IVIg) for Refractory and Difficult-to-treat Infections. 38
Epidemiology and clinical managment of XDR-TB: a systematic review. 37
Differences among multidrug-resistant tuberculosis patients in two metropolitan areas 37
Macrolides for chronic asthma 37
Corticosteroids for IPF: a systematic review 36
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 35
Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs. 34
Validation of the tuberculin skin test cut-off in BCG vaccinated individuals using the QuantiFERON-TB Gold 34
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. 33
Tuberculosis in prisons: anatomy of global neglect. 33
Interferon-{gamma} release assays for the diagnosis of latent M. tuberculosis infection: A systematic review and meta-analysis. 32
Blood tests for diagnosis of tuberculosis - Authors' reply. 32
Il trattamento della Tubercolosi 31
High risk of tuberculosis in health care workers in Romania. 31
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control. 31
Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test 31
Macrolides for chronic asthma. 30
The best on infections: update from the 2010 ERS Congress. 30
I nuovi test per la diagnosi di infezione tubercolare. 30
Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis 30
New tools for a better diagnosis of latent tuberculosis infection 30
Macrolides in the treatment of asthma and cystic fibrosis. 29
High risk of tuberculosis in health care workers in Romania 29
TB or not TB: update from the ERS Respiratory Infection Assembly 10. 29
Management of multidrug-resistant tuberculosis in Italy. 28
Performance of tests for latent tuberculosis in different groups of immunocompromised patients. 28
Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. 27
Mycobacterium tuberculosis induces CCL18 in human macrophages. 27
Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999 27
Routine Hospital Use of a New Commercial Whole Blood Interferon-γ Assay for the Diagnosis of Tuberculosis Infection. 25
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 25
Extensively drug-resistant tuberculosis, Italy and Germany. 24
Isoniazid preventive treatment: predictors of adverse events and treatment completion. 24
Recurrent respiratory infections and unusual radiology: a woman with Kartagener's syndrome 24
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000. 22
Latent tuberculous infection among foreign-born individuals applying to shelters in the metropolitan area of Milan 22
Extra-pulmonary tuberculosis and Xpert® MTB/RIF: all about meta-analyses? 21
Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group 21
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence 20
T-Cell Therapy: Options for Infectious Diseases 20
Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays 20
Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma 20
No association between Birt-Hogg-Dubé syndrome skin fibrofolliculomas and the first 10 described human polyomaviruses or human papillomaviruses. 19
Idiopathic pulmonary fibrosis in Sweden: report from the first year of activity of the Swedish IPF-Registry 19
Need for combined interventions and operational research to tackle tuberculous meningitis 19
Tuberculosis: Novel opportunities to control an old disease. 18
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? 17
Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: The case of two Nordic countries 16
Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays 15
Totale 3.340
Categoria #
all - tutte 12.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 0 0 14 1
2019/2020307 5 9 46 7 43 7 62 0 63 35 9 21
2020/2021743 4 56 34 59 214 52 45 1 88 34 62 94
2021/2022609 19 107 18 46 11 7 12 207 3 8 58 113
2022/20231.072 98 143 7 110 95 147 0 44 393 1 26 8
2023/2024303 21 57 22 10 4 3 59 3 68 5 51 0
Totale 3.340